Welcome to our regular round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

The incidence of gastroesophageal reflux disease (GERD) is higher among people taking glucagon-like peptide-1 receptor agonists (GLP-1...

Medical tourism for bariatric surgery needs urgent regulation to protect recipients' health, especially as the data show that tourist...

Spend an engaging hour with Researcher 2 Researcher   and Bariatric News   as we explore a range of topics in Bariatric and Metabolic...

Exposure to endocrine-disrupting chemicals in early life, including during gestation and infancy, results in a higher preference for...

Anti-obesity medications can significantly raise testosterone levels and improve health outcomes for men with obesity or type 2 diabetes,...

RefluxStop surgery (developed by Implantica) results in a favourable profile of food passageway-related outcomes throughout the five-year...

Using tirzepatide and menopause hormone therapy at the same time leads to increased weight loss in postmenopausal women with overweight...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help...

Cancer deaths linked to obesity have tripled in the US over the past two decades, according to a study being presented at ENDO 2025, the...

Pouch revision in combination with ring-augmented Roux-en-Y gastric bypass (raRYGB) – using a MiniMizer Ring - appears to be a promising...

Amylyx Pharmaceuticals has represented analyses from the Phase 2 PREVENT and Phase 2b clinical trials of avexitide, an investigational,...